1. Cessation of therapy during complete remission of childhood acute lymphocytic leukemia;Aur, R.J.A.; Simone, J.V.; Hustu, H.O.; Verzosa, M.S.; Pinkel, D.;New England Journal of Medicine,1974
2. Neurological complications of childhood leukaemia;Campbell, R.H.A.; Marshall, W.C.; Chessells, J.M.;Archives of Disease,1977
3. Irradiation, methotrexate toxicity, and the treatment of meningeal leukaemia;Duttera, M.J.; Bleyer, W.A.; Pomeroy, T.C.; Leventhal, C.M.; Leventhal, B.G.;Lancet,1973
4. Prevention of central nervous system leukemia by irradiation;Hustu, H.O.; Aur, R.J.A.; Verzosa, M.S.; Simone, J.V.; Pinkel, D.;Cancer,1973
5. Encephalopathy in acute leukaemia associated with methotrexate therapy. Archives of Disease in;Kay, H.E.M.; Knapton, P.J.; O'Sullivan, J.P.; Wells, D.G.; Harris, R.F.; Innes, E.M.; Stuart, J.; Schwartz, F.C.M.; Thompson, E.N.;Childhood; Treatment of acute lymphoblastic leukaemia: comparison of immunotherapy (BCG), intermittent methotrexate, and no therapy after a five-month intensive cytotoxic regimen (Concord Trial,1972